alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
Exhibit 31.2

CERTIFICATION UNDER

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Steven J. Kutcher, certify that:

1.
        I have reviewed this Amendment No. 1 to quarterly report on Form 10-QSB/A of CapSource Financial, Inc.;


2.
        Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;


3.
        Based on my knowledge, the financial statements, and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;


4.
        The registrants other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and have:


a)
        designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to me by others within those entities, particularly during the period in which this quarterly report is being prepared;


b)
        evaluated the effectiveness of the registrants disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this quarterly report based on such evaluation; and


c)
        disclosed in this report any change in the registrants internal control over financial reporting that occurred during the registrants most recent fiscal quarter (the registrants fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrants internal control over financial reporting;


5.
        We have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent functions):


a)
        all significant deficiencies and material weaknesses in the design or operation of internal controls over financial reporting which are reasonably likely to adversely affect the registrants ability to record, process, summarize and report financial data; and


b)
        any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants control over financial reporting.






DATE:   January 17, 2007
        
        By:
        /s/ Steven J. KutcherName: Steven J. KutcherChief Financial Officer andPrincipal Accounting Officer










---
#### In the Matter of Anne E. Adams, an Attorney, Resignor.

[874 NYS2d 830] —

Resignation accepted and name stricken from roll of attorneys. Present — Hurlbutt, J.P., Smith, Centra, Peradotto and Gorski, JJ. (Filed Mar. 6, 2009.)
EXHIBIT 31.2  CERTIFICATION OF CHIEF FINANCIAL OFFICER PURSUIT TO SECURTIES EXCHANGE ACT RULES 13a-14 AND 15d-14 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002  I, Janice Clarke, certify that:  1. I have reviewed this amended annual report on Form 10-KSB of Stellar Pharmaceuticals Inc. (previously Stellar International Inc.)  2. Based on my knowledge, this amended annual report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this amended annual report;  3. Based on my knowledge, the financial statements, and other financial information included in this amended annual report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this amended annual report;  4. The registrants other certifying officer and I, are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-14 and 15d-14) for the registrant and we have:  a) Designed such disclosure controls and procedures to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this amended annual report is being prepared; b) Evaluated the effectiveness of the registrants disclosure controls and procedures as of  a date within 90 days prior to the filing date of this amended annual report (the Evaluation Date); and c) Presented in this amended annual report our conclusions about the effectiveness of the disclosure controls and procedures based on our evaluation as of the Evaluation Date;  5. The registrants other certifying officer and I have disclosed, based on our most recent evaluation, to the registrants auditors and the audit committee of registrants board of directors (or persons performing the equivalent function):  a) All significant deficiencies in the design or operation of the internal controls which could adversely affect the registrants ability to record, process, summarize and report financial data and have identified for the registrants auditors any material weaknesses in internal controls; and b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrants internal controls; and  6.  The registrants other certifying officer and I have indicated in this amended annual report whether or not there were significant changes in internal controls or in other factors that could significantly affect internal controls subsequent to the date of our most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses.  Date:  July 13, 2006By:/s/Janice ClarkeJanice Clarke 
Chief Financial Officer
# C_2010125EN.01000802.xml

| 13.5.2010 | EN | Official Journal of the European Union | C 125/8 |
| --- | --- | --- | --- |

13.5.2010

EN

Official Journal of the European Union

C 125/8

---

Notice pursuant to Article 6(6)(f) of Protocol II concerning the definition of the concept of ‘originating products’ and methods of administrative cooperation to the Interim Partnership Agreement between the European Community of the one part and the Pacific States of the other part

2010/C 125/07

By the present notice interested parties are informed that Papua New Guinea has made on 13 March 2008 a notification to the European Commission in accordance with Article 6(6)(b) of Protocol II concerning the definition of the concept of ‘originating products’ and methods of administrative cooperation to the Interim Partnership Agreement between the European Community of the one part and the Pacific States of the other part (OJ L 272, 16.10.2009).

---
---

Exhibit 99.7


CERTIFICATION PURSUANT TO 18 U.S.C. § 1350, AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 In connection with the Annual Report of Burcon NutraScience Corporation (the “Company”) on Form 40-F for the year ended March 31, 2012 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Jade Cheng, the Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that: 1.

   The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and2.

   The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Date: July 12, 2012 “/s/ Jade Cheng”Jade Cheng Chief Financial Officer


---
# C_2019270EN.01001202.xml

| 12.8.2019 | EN | Official Journal of the European Union | C 270/12 |
| --- | --- | --- | --- |

12.8.2019

EN

Official Journal of the European Union

C 270/12

---

Judgment of the Court (Third Chamber) of 20 June 2019 (request for a preliminary ruling from the arbeidsrechtbank Antwerpen — Belgium) –Tine Vandenbon, Jamina Hakelbracht, Instituut voor de Gelijkheid van Vrouwen en Mannen v WTG Retail BVBA

(Case C-404/18) (1)

(Reference for a preliminary ruling - Social policy - Directive 2006/54/EC - Equal treatment of men and women - Access to employment and working conditions - Article 24 - Protection against retaliatory measures - Rejection of a candidate due to her pregnancy - Employee intervening in favour of that candidate - Dismissal of that employee)

(2019/C 270/14)

Language of the case: Dutch

Referring court

Arbeidsrechtbank Antwerpen

Parties to the main proceedings

Applicants: Tine Vandenbon, Jamina Hakelbracht, Instituut voor de Gelijkheid van Vrouwen en Mannen

Defendant: WTG Retail BVBA

Operative part of the judgment

Article 24 of Directive 2006/54/EC of the European Parliament and of the Council of 5 July 2006 on the implementation of the principle of equal opportunities and equal treatment of men and women in matters of employment and occupation must be interpreted as meaning that it precludes national legislation, such as that at issue in the main proceedings, under which, in a situation where a person who believes to be discriminated against on grounds of sex has lodged a complaint, an employee who has supported that person in that context is protected from retaliatory measures taken by the employer solely if that employee has intervened as a witness in the context of the investigation of that complaint and that that employee’s witness statement satisfies formal requirements laid down by that legislation.

---

(1)  OJ C 311, 3.9.2018.

---
# C_2010160EN.01001901.xml

| 19.6.2010 | EN | Official Journal of the European Union | C 160/19 |
| --------- | -- | -------------------------------------- | -------- |

---

Decision on a reorganisation measure in respect of ARFIN Compagnia di Assicurazioni e Riassicurazioni SpA

(Publication in accordance with Article 6 of Directive 2001/17/EC of the European Parliament and of the Council of 19 March 2001 on the reorganisation and winding-up of insurance undertakings)

2010/C 160/05

| Insurance undertaking | ARFIN Compagnia di Assicurazioni e Riassicurazioni SpA Viale Nazario Sauro 14 20124 Milano MI ITALIA | ARFIN Compagnia di Assicurazioni e Riassicurazioni SpA | Viale Nazario Sauro 14 | 20124 Milano MI | ITALIA |
| ------------------------------------------------------ | ----------------------------------------------------------------------------------------------------------------------------------------------------------------- | ------------------------------------------------------ | ---------------------- | --------------- | ------ |
| ARFIN Compagnia di Assicurazioni e Riassicurazioni SpA | | | | | |
| Viale Nazario Sauro 14 | | | | | |
| 20124 Milano MI | | | | | |
| ITALIA | | | | | |
| Date, entry into force and nature of the decision | ISVAP measure No 2795 of 14 April 2010 — Appointment of a Commissioner for interim management within the meaning of Article 230 of Legislative Decree No 209/2005 | | | | |
| Competent authorities | ISVAP Via del Quirinale 21 00187 Roma RM ITALIA | ISVAP | Via del Quirinale 21 | 00187 Roma RM | ITALIA |
| ISVAP | | | | | |
| Via del Quirinale 21 | | | | | |
| 00187 Roma RM | | | | | |
| ITALIA | | | | | |
| Supervisory authority | ISVAP Via del Quirinale 21 00187 Roma RM ITALIA | ISVAP | Via del Quirinale 21 | 00187 Roma RM | ITALIA |
| ISVAP | | | | | |
| Via del Quirinale 21 | | | | | |
| 00187 Roma RM | | | | | |
| ITALIA | | | | | |
| Commissioner appointed | Dott. Angelo Cremonese Viale Nazario Sauro 14 20124 Milano MI ITALIA | Dott. Angelo Cremonese | Viale Nazario Sauro 14 | 20124 Milano MI | ITALIA |
| Dott. Angelo Cremonese | | | | | |
| Viale Nazario Sauro 14 | | | | | |
| 20124 Milano MI | | | | | |
| ITALIA | | | | | |
| Applicable law | Italy
Article 230 of Legislative Decree No 209/2005 | | | | |

Under ISVAP measure No 2795 of 14 April 2010 Dott. Angelo Cremonese has been appointed within the meaning of Article 230 of Legislative Decree No 209 of 7 September 2005 as Commissioner for the interim management of ARFIN Compagnia di Assicurazioni e Riassicurazioni SpA, with head offices in Milan at Viale Nazario Sauro 14, for a maximum period of two months from the date of adoption of this measure. Consequently, the powers of the administrative and controlling bodies of the company are suspended.

---
#### Lijo Panghat, M.D., Appellant, v New York Downtown Hospital, Respondent.

Submitted December 5, 2011;

decided January 17, 2012

Reported below, 85 AD3d 473.

Motion for relief ancillary to the motion for leave to appeal herein dismissed upon the ground that it does not lie.
Exhibit 13.2

CERTIFICATION

Pursuant to 18 U.S.C. § 1350, the undersigned officer of Nidec Corporation (the Company) hereby certifies, to such officers knowledge, that the Companys annual report on Form 20-F for the year ended March 31, 2008 (the Report) fully complies with the requirements of Section 13(a) or 15(d), as applicable, of the Securities Exchange Act of 1934 and that the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated:  September 22, 2008

/s/   Yasunobu ToriyamaYasunobu Toriyama
Executive Vice President, Chief Financial and Accounting Officer and Director
##### 



EXHIBIT 13.1
 CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
  
    
    the amendment to the Annual Report of the Company
on Form 20-F/A No. 1 for the fiscal year ended
March 31, 2007 fully complies with the requirements
of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934; and
    
    the information contained in such report fairly
presents, in all material respects, the financial
condition and results of operation of the Company.
  /s/ Louis GriesLouis GriesChief Executive Officer /s/ Russell ChenuRussell ChenuChief Financial Officer
AEGIS SEF | 2829 Technology Forest Boulevard, Suite 260 | The Woodlands, Texas 77381

Chapter 1219

Natural Gasoline (Pentane) Option - Mt. Belvieu Natural Gasoline (LDH) - OPIS

DESCRIPTION

Monthly cash settled put and call options published by OPIS for the location specified in Floating Price A. 

FLOATING PRICE A

The Floating Price for each contract month is equal to the arithmetic average of the OPIS Mt. Belvieu Natural Gasoline 

(LDH) price for each business day that it is determined during the contract month.

OPTION CHARACTERISTICS

TRADING UNIT

On expiration of a Call Option, the value will be the difference between the average daily settlement price 

during the calendar month of the first nearby OPIS Mt. Belvieu Natural Gasoline (LDH) (as described in 

Floating Price A) and the strike price, or zero whichever is greater. On expiration of a Put Option, the value 

will be the difference between the strike price and the average daily settlement price during the calendar 

month of the first nearby OPIS Mt. Belvieu Natural Gasoline (LDH) (as described in Floating Price A), or zero 

whichever is greater.

TYPE OPTION

Cash-settled European-Style Average Price option which cannot be exercised prior to expiration.

CONTRACT UNIT AND VALUE

The contract quantity shall be U.S. gallons. Each contract shall be valued as the contract quantity multiplied by the 

settlement price.

LISTING CYCLE

Up to 120 consecutive monthly contract periods

PRICES AND FLUCTUATIONS

Prices shall be quoted in dollars and cents per gallon and prices shall be in multiples of $0.001 per gallon. The 

minimum price increment will be $0.0001. There shall be no maximum price fluctuation. 

TERMINATION OF TRADING

Posting of transactions shall cease on the last business day of the contract month.

FINAL SETTLEMENT

Delivery under the contract shall be by cash settlement. Final settlement, following termination of posting for a 

contract month, will be based on the Floating Price. The final settlement price will be the Floating Price calculated for 

each contract month.
#### STATE v. HINSON

No. 346P98

Case below: 127 N.C.App. 562

Petition by defendant for writ of certiorari to review the decision of the North Carolina Court of Appeals denied 5 November 1998.
# C_2010349EN.01001601.xml

| 22.12.2010 | EN | Official Journal of the European Union | C 349/16 |
| --- | --- | --- | --- |

22.12.2010

EN

Official Journal of the European Union

C 349/16

---

Communication from the Commission on the authority authorised to issue certificates of origin under Regulation (EU) No 1085/2010

2010/C 349/07

By Commission Regulation (EU) No 1085/2010 of 25 November 2010, published in
  Official Journal of the European Union L 310 of 26 November 2010, an import tariff quota has been opened for manioc starch and sweet potatoes.

Official Journal of the European Union

Article 3 of Commission Regulation (EU) No 1085/2010 of 25 November 2010 stipulates that entitlement to this quota is conditional on the presentation of a certificate of origin.

The following authority is authorised to issue certificates of origin under this Regulation:

| Department of Foreign Trade |
| --- |
| Ministry of Commerce |
| Bureau of Import-Export Certification |
| 44/100 Nonthaburi 1 Road |
| Nonthaburi 11000 |
| THAILAND |
| Tel. +66 25474829 / 66 25474832 / 66 25474825 |
| Fax +66 25474757 |
| E-mail: eximdft@moc.go.th |

Department of Foreign Trade

Ministry of Commerce

Bureau of Import-Export Certification

44/100 Nonthaburi 1 Road

Nonthaburi 11000

THAILAND

Tel. +66 25474829 / 66 25474832 / 66 25474825

Fax +66 25474757

E-mail: eximdft@moc.go.th

---
Court of Appeals of the State of Georgia

Clerk's Office, Atlanta, April 01, 2020.

I certify that the above is a true extract from the minutes 

of the Court of Appeals of Georgia.

Witness my signature and the seal of said court hereto 

affixed the day and year last above written.

, Clerk.

Court of Appeals 

of the State of Georgia

ATLANTA, April 01, 2020

The Court of Appeals hereby passes the following order

A20D0343. THERIAN WIMBUSH v. GWINNETT JUVENILE COURT et al.

Upon consideration of the Application for Discretionary Appeal, it is ordered that it be 

hereby DENIED.

LC NUMBERS:

19A015454
I 

111TH CONGRESS 

1ST SESSION H. R. 961 

To suspend temporarily the duty on phosphoric acid, lanthanum salt, cerium 

terbium-doped. 

IN THE HOUSE OF REPRESENTATIVES 

FEBRUARY 10, 2009 

Mr. PAUL introduced the following bill; which was referred to the Committee 

on Ways and Means 

A BILL 

To suspend temporarily the duty on phosphoric acid, 

lanthanum salt, cerium terbium-doped. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. PHOSPHORIC ACID, LANTHANUM SALT, CE4 RIUM TERBIUM-DOPED. 

5 (a) IN GENERAL.—Subchapter II of chapter 99 of 

6 the Harmonized Tariff Schedule of the United States is 

7 amended by inserting in numerical sequence the following 

8 new heading: 

‘‘ 9902.04.76 Phosphoric acid, lanthanum 

salt, cerium terbium-doped 

(CAS No. 95823–34–0) (provided for in subheading 

3206.50.00) ........................... Free No change No change On or before 

12/31/2012 ’’. 

mstockstill on PROD1PC66 with BILLS

2 

•HR 961 IH

1 (b) EFFECTIVE DATE.—The amendment made by 

2 subsection (a) applies to goods entered, or withdrawn from 

3 warehouse for consumption, on or after the 15th day after 

4 the date of the enactment of this Act. 

Æ 

mstockstill on PROD1PC66 with BILLS
1 ... T h i s pr oce edi n g ar i s es ou t of Cau s e N o. 2009- CR
- 8136, s t y l ed St at e o f T exas v. Jus t i n B osquez , i n the 3 7 9 th Jud i ci al D i st ri ct C o urt , B exar C o unt y , T exas, t he H o no rable Ro n R angel presi d i ng.

2 ... T h e r ec or d i n di ca t es t h at u p u n t i l Au g u s t 28, 2009, Al f r edo T r ev i n o r epr es en t ed r el at or . At a h ea r i n g on A ug ust 28 , 2 0 0 9 , relato r wa s ap p o i nted ne w co un sel, E d d i e A d am s. i i i i i i



### MEM ORA ND UM OP INION No
. 04 -0 9- 00 57 5- CR IN RE J ustin BO S QU EZ Orig inal Mandamus Proce eding 1 PER C URI AM Sitt ing: Catherine Stone, Chief Justice

Kar en Ang elini, J ustice Marialy n Ba rnar d, J ustice Deliver ed and F iled: September 23, 2009 PETI TI ON F OR WR I T OF MANDAMUS DEN I ED On Se pte mbe r 1 1, 20 09 , r e la tor Just in B os qu e z fi le d a

pe tit ion fo r w ri t of

mand a mus , complaining of the trial c ourt’s fa ilure to rule on his motion for discover y . Howeve r, counse l ha s been a ppointed to repre sent relator in the criminal proc eedingpending in the t rial court for which he is curre ntly confine d. 2 A c ri min a l de fe nd ant i s n ot e nti tle d to hy br id repr esentation. Se e Ro bin so n v . S tat e , 2 40 S.W. 3d

91 9, 92 2 ( Tex
. Cr im. Ap p. 20 07 ); Patrick v. Sta te , 906 S.W .2d 481, 498 (Tex. Crim. App. 1995). A trial cour t has no leg al dut y

to rule on a pr o04
- 09
- 00 57 5- CR

- 2- se motion filed with reg ard to a criminal proc eedingin which the d ef en d ant is repr esente d by counsel. See Robinson , 240 S.W .3d at 922. Consequently , the t rial court did not abuse its discretion by de c lin ingto r

ule on re la tor ’s pr o s e motion that relates dire ctly to his c onfinement ba sed on the criminal proc eedingpending in the t rial court. Acc ording ly , relator’s petit ion for writ of mandamus is denied. T EX . R. A PP . P. 52.8(a)
. Ad dit ion a lly , r e la tor fi le d an Ap pli c a tio n f or L e a ve to F ile Pe tit ion

fo r Wr it o f M and a mus . No leave is require d to file a pe ti t i o n fo r a writ of mandamus in this court. T EX . R. A PP . P. 52. There fore , relator’s motion for leave to file is DENI ED as moot. P E R C U R I A M DO NO T PU B L I SH